Search Thermo Fisher Scientific
Lipofectamine LTX® Reagent is a proprietary, animal-origin free formulation for the transfection of DNA into eukaryotic cells with low cytotoxicity. This reference provides a recommended procedure to transfect plasmid DNA into HT-29, human colon adenocarcinoma cells (ATCC No. HTB-38) using Lipofectamine LTX® Reagent.
Important Guidelines for Transfection
Follow these important guidelines when transfecting HT-29 cells using Lipofectamine LTX® Reagent:
Materials Needed
Have the following reagents on hand before beginning:
Culture vessel | Surface area per well | Volume plating medium | Cells per well | Volume dilution medium | DNA | Lipofectamine® LTX Reagent | PLUS™ Reagent |
---|---|---|---|---|---|---|---|
96-well | 0.3 cm2 | 100 μl | 3.0 x 104 | 20 μl | 150 ng | 0.75 - 1.0 μl | 0.15 μl |
48-well | 1 cm2 | 200 μl | 6.0 x 104 | 40 μl | 300 ng | 1.5 - 2.0 μl | 0.3 μl |
24-well | 2 cm2 | 500 μl | 1.5 x 105 | 100 μl | 750 ng | 3.75 - 5 μl | 0.75 μl |
12-well | 4 cm2 | 1 ml | 3.0 x 105 | 200 μl | 1.5 μg | 7.5 - 10 μl | 1.5 μl |
6-well | 10 cm2 | 2 ml | 7.5 x 105 | 500 μl | 3.75 μg | 18.75 - 25 μl | 3.75 μl |